Focused Incentive Spirometry Monitoring to Reduce Postoperative Oxygen Therapy and Respiratory Complications After Bariatric Surgery
Status: | Recruiting |
---|---|
Healthy: | No |
Age Range: | 18 - 80 |
Updated: | 3/10/2019 |
Start Date: | August 2016 |
End Date: | December 2020 |
Contact: | Colleen Dingmann, R.N. Ph.D. |
Email: | colleen.dingmann@ucdenver.edu |
Phone: | 720-234-6110 |
Postoperative (PO) hypoventilation, atelectasis and hypoxemia after bariatric surgery are
common and multifactorial, contributing to prolonged oxygen (O2) therapy after surgery and
even at hospital discharge. Incentive spirometry (IS) is recommended postoperatively but its
success in preventing postoperative atelectasis and hypoxemia (POH) heavily depends on
patient compliance with IS effort and frequency. The investigators hypothesize that a focused
education preoperatively on IS for POH and intensive monitoring of patient compliance with IS
therapy in the early postoperative period shortens postoperative oxygen therapy, decreases
POH episodes, and improves respiratory outcomes after bariatric surgery, compared to patients
receiving standard of care.
common and multifactorial, contributing to prolonged oxygen (O2) therapy after surgery and
even at hospital discharge. Incentive spirometry (IS) is recommended postoperatively but its
success in preventing postoperative atelectasis and hypoxemia (POH) heavily depends on
patient compliance with IS effort and frequency. The investigators hypothesize that a focused
education preoperatively on IS for POH and intensive monitoring of patient compliance with IS
therapy in the early postoperative period shortens postoperative oxygen therapy, decreases
POH episodes, and improves respiratory outcomes after bariatric surgery, compared to patients
receiving standard of care.
Inclusion Criteria:
- Patients having planned elective bariatric surgery at University of Colorado Hospital
Exclusion Criteria:
- Emergency procedure
- Oxygen therapy within the previous 30 days
- Smoking within the previous 30 days
- Inability or refusal to provide consent
We found this trial at
1
site
12605 East 16th Avenue
Aurora, Colorado 80045
Aurora, Colorado 80045
720-848-0000
Principal Investigator: Ana Fernandez-Bustamante, M.D., Ph.D.
Phone: 303-724-7494
University of Colorado Hospital, Site Top medical professionals, superior medicine and progressive change make University...
Click here to add this to my saved trials